
Dr. Mohammed Paika discusses the mechanisms and implications of retatrutide in weight loss and obesity treatment.
#Retatrutide #GLP1 #WeightLossScience #ObesityMedicine #GLP1Masterclass Is retatrutide the real deal, or just another overhyped GLP-1 headline? In this video, Dr. Mohammed Paika — board-certified in Internal Medicine and Obesity Medicine — breaks down exactly how retatrutide's triple-hormone mechanism (GLP-1 + GIP + glucagon) works, what the Phase 2 trial data actually shows, and where the online hype outruns the evidence. You'll learn why weight loss and fat loss aren't the same thing, why muscle loss is the most overlooked risk on any GLP-1 medication (and exactly how to prevent it), what's really happening in your brain on these drugs, and the honest side-effect and safety picture — including the boxed warning most videos skip. Retatrutide is still investigational and has not been FDA-approved. This video is for education only and is not medical advice — always talk to your own physician before starting or changing any treatment. Want the complete framework for using GLP-1 therapy correctly — protein targets, a 12-week body recomposition program, and real answers to the questions patients ask every day in clinic? Check out the GLP-1 Masterclass at https://drmohammedpaika.com…
Explore listener stats, chart rankings, contacts and more on the Dr. Paika Podcast podcast page.